Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis

scientific article

Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1036495410
P356DOI10.1007/S00125-007-0666-4
P8608Fatcat IDrelease_uu3t6p434rgqxih5dnkczgmzsi
P932PMC publication ID1914278
P698PubMed publication ID17415544
P5875ResearchGate publication ID6405784

P50authorJohn J. P. KasteleinQ110410211
P2093author name stringA Kontush
B A Hutten
C B Brouwer
E de Groot
E S G Stroes
F Holleman
H Vink
J B L Hoekstra
J Gort
M J Chapman
M Nieuwdorp
P2860cites workIntensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesQ22250887
Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitusQ28268390
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trialQ28273112
Permeation of the luminal capillary glycocalyx is determined by hyaluronanQ30304200
Inhibitors of the hyaluronidasesQ34517580
Measurement of arterial wall thickness as a surrogate marker for atherosclerosisQ35806072
The endothelial glycocalyx: a potential barrier between health and vascular diseaseQ36251700
Mechanotransduction and the glycocalyxQ36440487
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research GroupQ36900139
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitusQ37239783
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesionsQ37486465
Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitusQ40933115
Is serum hyaluronan a helpful tool in the management of patients with liver diseases?Q41566309
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosionQ44177932
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosisQ44574970
Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK ratsQ44613074
L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexesQ45025030
Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosisQ45261400
Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesionsQ46284879
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trialQ46468942
The role of carotid arterial intima-media thickness in predicting clinical coronary eventsQ46619804
Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcationQ46697077
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo.Q46917089
Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion.Q52538626
Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaqueQ72401496
The endothelial glycocalyx protects against myocardial edemaQ73127923
Circulating hyaluronan and hyaluronidase are increased in diabetic ratsQ73683385
A microtiter-based assay for hyaluronidase activity not requiring specialized reagentsQ73702186
Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetesQ74530211
Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetesQ82984599
High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research databaseQ82985834
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecttype-1 diabetesQ124407
atherosclerosisQ12252367
P304page(s)1288-93
P577publication date2007-06-01
P1433published inDiabetologiaQ5270140
P1476titlePerturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis
P478volume50

Reverse relations

cites work (P2860)
Q37422600C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction
Q26777077Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population
Q26828872Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases
Q63488623Diabetic fatty liver disease is associated with specific changes in blood-borne markers
Q36253868Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy.
Q46165413Effect of anticoagulants on the plasma hyaluronidase activities.
Q34283956Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
Q89030137Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases
Q35696044Endothelial barrier dysfunction in diabetic conduit arteries: a novel method to quantify filtration
Q50058490Endothelial nanomechanics in the context of endothelial (dys)function and inflammation
Q33775709Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice
Q24644869Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers
Q33400488Glomerular endothelium: a porous sieve and formidable barrier.
Q34636380Hyaluronan as an immune regulator in human diseases.
Q35660196Hyaluronan regulation of vascular integrity
Q26799151Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?
Q48159837Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan
Q26786057Hyperglycemia-Induced Changes in Hyaluronan Contribute to Impaired Skin Wound Healing in Diabetes: Review and Perspective
Q36075964Impact of enzymatic degradation of the endothelial glycocalyx on vascular permeability in an awake hamster model.
Q33857901Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation
Q38209920Modulation of endothelial glycocalyx structure under inflammatory conditions.
Q34074465NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.
Q92792357Noninvasive sublingual microvascular imaging reveals sex-specific reduction in glycocalyx barrier properties in patients with coronary artery disease
Q54444900Peroxisome proliferator-activated receptor γ agonists attenuate hyperglycaemia-induced hyaluronan secretion in vascular smooth muscle cells by inhibiting PKCβ2.
Q99561828Retinal Physiology and Circulation: Effect of Diabetes
Q37517028Serum levels of endothelial glycocalyx constituents in women at 20 weeks' gestation who later develop gestational diabetes mellitus compared to matched controls: a pilot study.
Q24301715Shear stress increases endothelial hyaluronan synthase 2 and hyaluronan synthesis especially in regard to an atheroprotective flow profile
Q64115102Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study

Search more.